CPC
SLXP

Cookson Peirce & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Cookson Peirce & Co’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-24,720
Closed -$3.86M – 143
2014
Q3 		$3.86M Buy
24,720
+780
+3% +$113K 0.9% 39
2014
Q2 		$2.95M Buy
23,940
+1,410
+6% +$156K 0.71% 45
2014
Q1 		$2.33M Buy
22,530
+150
+0.7% +$15.4K 0.58% 50
2013
Q4 		$2.01M Buy
22,380
+1,300
+6% +$104K 0.53% 54
2013
Q3 		$1.41M Buy
+21,080
New +$1.45M 0.39% 59

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cookson Peirce & Co's SLXP Position: Q4 2014 in Review

Cookson Peirce & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 24,720 shares — an estimated $3.86M sold.

Cookson Peirce & Co first reported a position in SLXP in Q3 2013 and held it in 5 quarters. The position peaked at $3.86M in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Cookson Peirce & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • Cookson Peirce & Co sold 24,720 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $3.86M.
  • Cookson Peirce & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 5 quarters.
  • Cookson Peirce & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.86M in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Cookson Peirce & Co's 13F filing for Q4 2014, filed 6 Feb 2015.